Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

AURONEXT PHARMA PRIVATE LIMITED

Amalgamated

AURONEXT PHARMA PRIVATE LIMITED having CIN U74999TG2009PTC109591 is 15 years , 11 month & 5 days old Private Indian Company incorporated on 02 Jul 2009. It is classified as Non-government company and is registered at ROC Hyderabad. Its authorized share capital is Rs. 2,550,000,000 and its paid up capital is Rs. 1,249,840,280. It's NIC code is 74999 (which is part of its CIN).

As per the NIC code, it is involved in Other Business Activities N.E.C. . AURONEXT PHARMA Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 06-19-2023. Directors of AURONEXT PHARMA are Madan mohan reddy Mettu and Madan mohan reddy Mettu.

AURONEXT PHARMA ' Corporate Identification Number (CIN) is U74999TG2009PTC109591 and its registration number is 109591. Users may contact AURONEXT PHARMA on its Email address - cs@aurobindo.com Registered address of AURONEXT PHARMA is Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak,Hyderabad,Telangana,India-500032. Current status of AURONEXT PHARMA PRIVATE LIMITED is - Amalgamated.

Key Indicators

Authorised Capital
2,550,000,000

as on 07/06/2025

Paid Up Capital
1,249,840,280

as on 07/06/2025

Company Age
15 Year, 11 Months
Last Filing with ROC
1 Year, 11 Months

Company Information

CIN U74999TG2009PTC109591
Company Status Amalgamated
Registration Number 109591
Date of Incorporation 07/02/2009
RoC ROC Hyderabad
Company Age 15 years & 344 days
Authorized Capital ₹ 2550000000
Paid-up capital ₹ 1249840280
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Private
Activity Other Business Activities N.E.C.
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2023

Contact

Email ID cs@aurobindo.com
Address S R Nagar Hyderabad Telangana India 500038
Website aurobindo.com
Contact Number +91*******

Location on Map

Director

Designation Name Date OF Appointment DIN PAN Tenure
Director
. SAPNA
03/08/2023 08434059 *****0511H 2 years
Director
JACOB JOSEPH
07/01/2021 08432306 *****4448A 3 years
Director
VENKATA RADHAKRISHNA RACHARLA
04/15/2019 00763862 *****5367F 6 years
Director
SARATH CHANDRA REDDY PENAKA
03/19/2024 01628013 1 years
Director
MADAN MOHAN REDDY METTU
05/12/2023 01284266 2 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
APL RESEARCH CENTRE LIMITED
Amalgamated
12,26,00,000.00 2 Telangana
AUROZYMES LIMITED
Amalgamated
5,00,000.00 2 Telangana
ALV SHAMSHABAD PRIVATE LIMITED
Active
1,00,000.00 1 Telangana
CUREPRO PARENTERALS LIMITED
Amalgamated
13,31,01,070.00 2 Telangana
AURYN LABS LIMITED
Strike Off
5,00,000.00 2 Telangana
TRIDENT LIFE SCIENCES LIMITED
Amalgamated
1,60,000.00 2 Telangana
EUGIA STERILES PRIVATE LIMITED
Active
44,25,00,000.00 2 Telangana
ROSA AVENUES INDIA PRIVATE LIMITED
Strike Off
1,00,000.00 2 Telangana
AXIS CLINICALS INDIA LIMITED
Strike Off
5,00,000.00 2 Telangana
AUROBINDO PHARMA FOUNDATION
Active
1,00,000.00 2 Telangana
CURATEQ BIOLOGICS PRIVATE LIMITED
Active
1,00,00,00,000.00 2 Telangana
EUGIA PHARMA SPECIALITIES LIMITED
Active
6,21,00,86,930.00 2 Telangana
AURO VACCINES PRIVATE LIMITED
Active
10,00,000.00 2 Telangana
EUGIA SEZ PRIVATE LIMITED
Active
3,38,00,00,000.00 2 Telangana
OREMSI PLASTICS PRIVATE LIMITED
Strike Off
1,29,000.00 2 Telangana
AUROZEST PRIVATE LIMITED
Active
10,00,000.00 2 Telangana
APL HEALTHCARE LIMITED
Active
2,22,00,00,000.00 2 Telangana
AURO PEPTIDES LIMITED
Active
2,47,85,00,000.00 2 Telangana
CREST CELLULOSE PRIVATE LIMITED
Active
60,55,01,570.00 2 Maharashtra

Charges on assets

1

YES BANK LIMITED

No. of Loans: 1

Total Amount: 350,000,000.00 cr

2

Axis Bank Limited

No. of Loans: 1

Total Amount: 15,000,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
YES BANK LIMITED Dr A B Road, Worli 350,000,000 21 Jul, 2016 04 Sep, 2018 08 Feb, 2021 Closed
Axis Bank Limited Begumpet 15,000,000 02 Feb, 2010 07 Jan, 2017 10 Feb, 2017 Closed

Registered Details

CIN
U74999TG2009PTC109591
PAN
U74999TG2009PTC109591
Incorporation
2 years
Company Email
cs@aurobindo.com
Paid up Capital
₹ 1,249,840,280
Authorised Capital
₹ 2,550,000,000
Type
Private Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Industry

Other Business Activities N.E.C.

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 9.29%
₹ 140,987.4
EBITDA arrow 29%
₹ 135,987.4
Net Profit arrow 29%
₹ 135,987.4
Networth arrow 29%
₹ 135,987.4
Borrowings arrow 9.29%
₹ 140,987.4
Assets arrow 9.29%
₹ 140,987.4
Gross Margin arrow 9.29%
₹ 140,987.4
Operating Margin arrow 29%
₹ 135,987.4
Net Profit Margin arrow 29%
₹ 135,987.4
Return on Equity arrow 29%
₹ 135,987.4
ROCE arrow 9.29%
₹ 140,987.4
Debt to Equity arrow 9.29%
₹ 140,987.4

Financial Highlights

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + lock lock lock lock lock
(a) Share capita lock lock lock lock lock
(b) Reserves and surplus lock lock lock lock lock
(c) Money received against share warrants lock lock lock lock lock
(2) Share application money pending allotment lock lock lock lock lock
(3) Non-current liabilities + lock lock lock lock lock
(a) Long-term borrowings lock lock lock lock lock
(b) Deferred tax liabilities (Net) lock lock lock lock lock
(c) Other Long-term liabilities lock lock lock lock lock
(d) Long-term provisions lock lock lock lock lock
(4) Current liabilities + lock lock lock lock lock
(a) Short-term borrowings lock lock lock lock lock
(b) Trade payables lock lock lock lock lock
(A) total outstanding dues of micro enterprises and small enterprises; and lock lock lock lock lock
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. lock lock lock lock lock
(c) Other current liabilities lock lock lock lock lock
(d) Short-term provisions lock lock lock lock lock
Total lock lock lock lock lock
ASSETS
Non-current assets + lock lock lock lock lock
(a) [Property, Plant and Equipment] lock lock lock lock lock
(i) Tangible assets lock lock lock lock lock
(ii) Intangible assets lock lock lock lock lock
(iii)Capital work-in-progress lock lock lock lock lock
(iv) Intangible assets under development lock lock lock lock lock
(b) Non-current investments lock lock lock lock lock
(c) Deferred tax assets (net) lock lock lock lock lock
(d) Long-term loans and advances lock lock lock lock lock
(e) Other non-current assets lock lock lock lock lock
(2) Current assets + lock lock lock lock lock
(a) Current investments lock lock lock lock lock
(b) Inventories lock lock lock lock lock
(c) Trade receivables lock lock lock lock lock
(d) Cash and cash equivalents lock lock lock lock lock
(e) Short-term loans and advances lock lock lock lock lock
(f) Other current assets lock lock lock lock lock
Total assets lock lock lock lock lock

Profit & Loss

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit + lock lock lock
Operating margin % lock lock lock
Other income
Interest lock lock lock
Depreciation lock lock lock
Exceptional items
Profit before tax
Tax lock lock lock
Profit - disc. ops lock lock lock
Net profit lock lock lock
Net margin % lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR crores
Solvency +
Total Debt/Equity
Net Debt/Equity lock lock lock
Total Debt/Assets
Total Assets/Equity
Liquidity +
Current Ratio
Quick Ratio
Interest Coverage
Performance lock lock lock
Gross Margin
Operating Margin
Net Margin
Return + lock lock lock
Return on Equity
Pre-tax ROCE lock lock lock
Return on Assets lock lock lock
Pre-tax ROIC lock lock lock
Efficiency + lock lock lock
Days Payable lock lock lock
Days Inventory lock lock lock
Days Receivable lock lock lock
Fixed Asset Turnover lock lock lock
Total Asset Turnover lock lock lock
Working Capital lock lock lock
Cash Conversion Cycle lock lock lock
Working Capital Days lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Auronext Pharma Private Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Auronext Pharma Private Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Auronext Pharma Private Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of Auronext Pharma Private Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Auronext Pharma Private Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Auronext Pharma Private Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Auronext Pharma Private Limited

What is AURONEXT PHARMA PRIVATE LIMITED ?

AURONEXT PHARMA PRIVATE LIMITED having CIN U74999TG2009PTC109591 is 2 years month old Private Indian Company incorporated with MCA on 12 May 2023. AURONEXT PHARMA PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Hyderabad with an Authorized Share Capital of 2,550,000,000 and paid-up capital is 1,249,840,280.

What is the CIN of AURONEXT PHARMA PRIVATE LIMITED?

CIN of AURONEXT PHARMA PRIVATE LIMITED is U74999TG2009PTC109591.

Where is AURONEXT PHARMA PRIVATE LIMITED located?

Address of AURONEXT PHARMA PRIVATE LIMITED is Galaxy, floors 22-24, plot no. 1, survey no. 83/1 hyderabad knowledge city, raidurg panmak,hyderabad,telangana,india-500032,.

Who are the directors of AURONEXT PHARMA PRIVATE LIMITED ?

The company has 10 directors/key management personnel . Sapna,jacob Joseph,venkata Radhakrishna Racharla,ravi Yellapragada,sarath Chandra Reddy Penaka,madan Mohan Reddy Mettu,. Sapna,u74999tg2009ptc109591 U74999tg2009ptc109591,sarath Chandra Reddy Penaka,madan Mohan Reddy Mettu,

What is the contact details of AURONEXT PHARMA PRIVATE LIMITED ?

Email : cs@aurobindo.com
Address : S R Nagar Hyderabad Telangana India 500038

What does AURONEXT PHARMA PRIVATE LIMITED do?

AURONEXT PHARMA PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing

Popular Search

Top Companies in your State

Enquiry